Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 706
Selected: 0
NCT IDTitle
NCT01069419Observation of Treatment With Certolizumab Pegol in Daily Practice
NCT02873767A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers
NCT00438451Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs
NCT01292837A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures
NCT01710657A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures
NCT01463059Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy
NCT00150761Facial Thermography Study of Levocetirizine Versus Cetirizine
NCT02552212Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS
NCT06312566A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Japanese Male Study Participants
NCT03695094A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil
NCT00699283A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures
NCT01390220Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters
NCT02890147Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control
NCT02969525A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis
NCT03778515Novel Quantitative MRI for Axial Spondyloarthritis
NCT01443364Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis
NCT01725009Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males
NCT01087788Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
NCT01405508Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy
NCT04867642A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease
NCT00484536Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
NCT04225871Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
NCT02823145An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
NCT01817972Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease
NCT04901195A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
NCT00422422Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
NCT02117141To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules
NCT02710890Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
NCT00868608Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
NCT06336343Bimekizumab in Plaque Psoriasis
NCT01506882An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy
NCT01210690Observational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral Solution
NCT00160550Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures
NCT00521040Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR
NCT00653224A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis
NCT01764321Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors
NCT04185415A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP)
NCT02905006Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis
NCT00843778Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study
NCT00899678The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents
NCT00861068A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).
NCT03517423Brivaracetam: a Prospective and Multicentre Post-marketing Observational Study
NCT01964560A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures
NCT00329303Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis
NCT00884325Management of Pruritus With Xyzal in Atopic Dermatitis
NCT07663240Epilepsy Emergency Department High Utilizer Program
NCT00453583Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
NCT00295022Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects
NCT00588302Moexipril for Primary Biliary Cirrhosis
NCT00307931Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab